Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
09/2005
09/14/2005CN1668703A Charge transport compositions on the basis of triarylmethanes and their use in electronic devices
09/14/2005CN1668621A Diazabicyclononane and -decane derivatives and their use as opioid receptor ligands
09/14/2005CN1668620A 1-heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands
09/14/2005CN1668617A Process for the preparation of imidazo(1, 2-A)pyridine-3-acetamides
09/14/2005CN1668616A Charge transport compositions comprising fluorizated quinazoline derivatives
09/14/2005CN1668615A Novel benzimidazole derivatives
09/14/2005CN1668611A 1-[(indol-3-yl)carbonyl] piperazine derivatives
09/14/2005CN1668608A Heterodiamondoids
09/14/2005CN1668598A Use of chemotherapeutic agents
09/14/2005CN1668574A Process for the preparation of phenylalanine enamide derivatives
09/13/2005US6943255 Process for imidazo[4,5-c]pyridin-4-amines
09/13/2005US6943188 For manufacture of medicament for use in treating asthma, multiple sclerosis, inflammatory disease
09/13/2005US6943175 Nitrogen compounds such as N-(3,5-dibromobenzyl)-N'-(1H-imidazo[4,5-b]pyridin-2-yl)-propane-1,3-diamine, used as inhibitors of methionyl transfer RNA synthetases in bacteria; antibiotics; bactericides
09/13/2005US6943174 6,5-Fused bicyclic heterocycles
09/13/2005US6943165 Compound and method for the treatment of pain
09/13/2005US6943156 3-(5,6,7,8-Tetrahydro-(1,8)naphthyridin-2-yl)-ethoxy)-11H-di-b enzo(1,4)oxazepin-10-yl)-acetic acid; inhibiting bone resorption; vascular restenosis; osteoporosis; angiogenesis inhibitors; diabetic retinopathy; anticarcinogenic agents
09/13/2005US6942966 Methods for processing chemical compounds having reactive functional groups
09/13/2005CA2358724C New cyclobutene-dione derivatives, their method of preparation and pharmaceutical compositions containing them
09/13/2005CA2216099C Alpha-substituted pyrimidine-thioalkyl and alkylether compounds as inhibitors of viral reverse transcriptase
09/09/2005WO2005082905A1 Bicyclic heterocyclic compound
09/09/2005WO2005082904A1 Preventive and/or therapeutic agent for neutrophilic inflammation disease
09/09/2005WO2005082903A1 2-(pyridin-3-ylamino)-pyrido[2,3-d]pyrimidin-7-ones
09/09/2005WO2005082895A1 Novel carboxamides for use as xa inhibitors
09/09/2005WO2005082889A1 Piperidinyl targeting compounds that selectively bind integrins
09/09/2005WO2005082887A1 Pyrimidine derivative
09/09/2005WO2005082874A1 Novel benzothiazepine and benzothiepine compounds
09/09/2005WO2005082865A1 Fused bicyclic pyrimidine derivative
09/09/2005WO2005082367A1 Kinase inhibitors
09/09/2005WO2005082079A2 Tetracyclic lactam derivatives and uses thereof
09/09/2005WO2005058884A3 Cyclopropane compounds and pharmaceutical use thereof
09/09/2005WO2005046611A3 Glucoimidazole and polyhydroxycyclohexenyl amine derivatives to treat gaucher disease
09/09/2005WO2005014584A8 3-(indol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones,3-(benzimidazol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones, and 3-(indolin-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones; their preparation and use as modulators of apoptosis
09/09/2005CA2557541A1 Pyrimidine derivatives
09/09/2005CA2557276A1 Preventive and/or therapeutic agent for neutrophilic inflammatory diseases
09/09/2005CA2556768A1 Piperidinyl targeting compounds that selectively bind integrins
09/09/2005CA2556738A1 Tetracyclic lactam derivatives and uses thereof
09/09/2005CA2555724A1 2-(pyridin-3-ylamino)-pyrido[2,3-d]pyrimidin-7-ones
09/08/2005US20050197380 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands
09/08/2005US20050197371 Urea derivatives as PDGFR modulators
09/08/2005US20050197367 Novel bicyclic compounds as modulators of androgen receptor function and method
09/08/2005US20050197362 Preventives/remedies for urinary disturbance
09/08/2005US20050197359 Bicyclic modulators of androgen receptor function
09/08/2005US20050197358 Administration of N-[4-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamide to induce cytokine biosynthesis or as a viricide or anticarcinogenic agent
09/08/2005US20050197352 Imidazo-substituted compounds as p38 kinase inhibitors
09/08/2005US20050197340 1-[3-(2-chlorophenyl)-6-(2,4-difluorophenoxy)-1H-pyrazolo[3,4-d]pyrimidin-4-ylamino]propan-2-ol; inhibitor of p38 (cyclin-dependent and tyrosine) kinase, tumor necrosis factor, interleukin-1; antiinflammatory agent; arthritis, Crohns disease, irritable bowel syndrome, adult respiratory distress syndrom
09/08/2005US20050197337 Aminomethylpyrimidines as allosteric enhancers of the GABAB receptors
09/08/2005US20050197330 Heterocyclic GABAA subtype selective receptor modulators
09/08/2005US20050197328 2-(4-amino-furazan-3-yl)-1-ethyl-N-[(2R)-2-morpholinylmethyl]-1H-imidazo[4,5-c]pyridine-7-carboxamide; Mitogen- and Stress-Activated Protein (MSK) and Rho (guanosine triphosphate) 1 or 2 kinase inhibitor; neurodegenerative diaeases; antiinflammatory, anticarcinogenic, antiviral and antibacterial agent
09/08/2005US20050197320 Phosphonate and sulfide substituted imidazole compounds; antihuman immunodeficiency viral agents
09/07/2005EP1571148A1 3-phenyl-cinnoline homologue and antitumor agent containing the same
09/07/2005EP1571144A1 Hydroxyalkylated cyclic diamine compound
09/07/2005EP1569942A2 Tricyclic aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2
09/07/2005EP1569938A1 Method of making tricyclic aminocyanopyridine compounds
09/07/2005EP1569936A1 Novel substituted imidazo-pyridinones and imidazo-pyridazeiones, the production and use thereof as medicaments
09/07/2005EP1569935A1 Heterocyclic compounds, preparation method thereof and use of same as medicaments, such as anti-bacterial medicaments and beta-lactamase inhibitors
09/07/2005EP1569934A2 Cyclopropyl compounds as ccr5 antagonists
09/07/2005EP1569933A1 Pyrrolidine and azetidine compounds as ccr5 antagonists
09/07/2005EP1569932A1 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2
09/07/2005EP1569931A1 Heterocyclic compounds as ccr5 antagonists
09/07/2005EP1569926A1 Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
09/07/2005EP1569925A1 2-substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
09/07/2005EP1569904A1 Substituted arylalcanoic acid derivatives as ppar pan agonists with potent antihyperglycemic and antihyperlipidemic activity
09/07/2005EP1569647A2 Cyclohexyl compounds as ccr5 antagonists
09/07/2005EP1569644A2 Indolizine compounds
09/07/2005EP1569642A1 Use of canthin-6-one, plant extracts containing same and derivatives thereof in the treatment of trypanosomiases
09/07/2005EP1569637A1 Bicyclic-substituted amines as histamine-3 receptor ligands
09/07/2005EP1495023B1 Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same
09/07/2005EP1458717B1 Aroyl pyridinones
09/07/2005EP1368342B1 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors
09/07/2005EP1282621B1 Vitronectin receptor antagonists
09/07/2005EP1214314B1 Aminopiperidine derivatives as antibacterials
09/07/2005EP1187812B1 Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors
09/07/2005EP1042295B1 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
09/07/2005CN1666577A Electronic devices made with electron transport and/or anti-quenching layers
09/07/2005CN1666357A Polymeric charge transport compositions and electronic devices made with such compositions
09/07/2005CN1665818A N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
09/07/2005CN1665815A Novel tetracyclo-aryl-carbonyl indoles used as therapeutical agents with 5-hydroxy-tryptamine receptor affinity, their preparation process and pharmaceutical compounds containing same
09/07/2005CN1665813A Process and intermediates for making non-nucleoside HIV-1 reverse transcriptase inhibitors
09/07/2005CN1665812A Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for the treatment of obesity
09/07/2005CN1665811A Carbamate-substituted pyrazolopyridines
09/07/2005CN1665810A Inhibitors of JAK and CDK2 protein kinases
09/07/2005CN1665809A Azaindoles
09/07/2005CN1665789A Diaminopyrimidinecarboxa mide derivative
09/07/2005CN1665785A 2-cyano-4-fluoropyrrolidine derivative or its salt
09/07/2005CN1665780A Tricyclic steroid hormone nuclear receptor modulators
09/07/2005CN1665512A Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases
09/07/2005CN1217945C CRF receptor antagonists and methods relating thereto
09/07/2005CN1217944C Crystal modification D of 8-cyano-1-cyclopropyl-7-(1S, 6S-2, 8-diazabicyclo-[4.3.0] nonan-8-yl)-6-fluoro-1, 4-dihydro-4-oxo-3-quinoline carboxylic acid
09/07/2005CN1217936C Heterocyclic compounds having sulfonamide
09/06/2005US6939874 Substituted pyrimidinyl derivatives and methods of use
09/06/2005US6939870 Heterocyclic amines such as 3-[2-(4-(1H-indol-3-yl)-3,6-dihydro-1(2H)-pyridinyl)ethyl]-6-7-dimethoxy-4(3H)-quinazolinone, used as antidepressants or anxiolytic agents for prophylaxis of psychological disorders
09/06/2005CA2137673C Novel 4-[3-benzofuranyl]piperidinyl and 4-[3-benzothienyl]piperidinyl derivatives
09/01/2005WO2005080399A1 Fused heterotetracyclic compounds and use tehreof as hcv polymerase inhibitor
09/01/2005WO2005080394A1 4-substituted piperidine derivatives
09/01/2005WO2005080393A1 Compounds and compositions as protein kinase inhibitors
09/01/2005WO2005080392A1 Pyrazoloquinolone derivative and use thereof
09/01/2005WO2005080391A1 Prodrugs of substituted amino heterobicycles which modulate the function of the vanilloid-1 receptor (vr1)
09/01/2005WO2005080390A1 Imidazopyridine derivatives as bsr-3 antagonists
09/01/2005WO2005080380A1 Kinase inhibitors
09/01/2005WO2005080378A1 Fused pyridazine derivatives
1 ... 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 ... 646